Kymera Therapeutics KYMR
NASDAQ KYMR
$107.39 -2.73 (-2.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kymera Therapeutics (KYMR) Depreciation and Depletion (2019 - 2026)

Updated

Kymera Therapeutics (KYMR) reported Depreciation and Depletion of $1.6 million for Q2 2026, down 5.9% from $1.7 million a year earlier and unchanged from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) Depreciation and Depletion (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kymera Therapeutics' Depreciation and Depletion came in at $8.2 million, up 12.3% year-over-year; for FY2025, it was $8.3 million, up 12.2% from FY2024.

  • Depreciation and Depletion has increased for six consecutive years, with a five-year compound annual growth rate of 35.8% (FY2020 to FY2025).
  • By year, Depreciation and Depletion came in at $7.4 million in FY2024 (+105.6%), $3.6 million in FY2023 (+20.0%), $3 million in FY2022 (+25.0%) and $2.4 million in FY2021 (+33.3%).
  • Five-year quarterly Depreciation and Depletion spans a low of $700.00 in Q3 2021 and a high of $2.9 million in Q4 2025.
  • Year over year, Depreciation and Depletion gained in five of the last eight quarters, with growth averaging 35.6%.
  • The high point for year-over-year Depreciation and Depletion in five years was Q4 2021 (growth of 379.7%); the low point was Q3 2021 (a decline of 99.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.6 million (Q1 2026), $2.9 million (Q4 2025) and $2.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Kymera Therapeutics 8.89 Bn 6.19 Bn - 1.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Mn
Mar 31, 2026 1.60 Mn
Dec 31, 2025 2.90 Mn
Sep 30, 2025 2.10 Mn
Jun 30, 2025 1.70 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 2.00 Mn
Sep 30, 2024 2.00 Mn
Jun 30, 2024 1.90 Mn
Mar 31, 2024 1.50 Mn
Dec 31, 2023 900,000.00
Sep 30, 2023 900,000.00
Jun 30, 2023 900,000.00
Mar 31, 2023 900,000.00
Dec 31, 2022 800,000.00
Sep 30, 2022 800,000.00
Jun 30, 2022 700,000.00
Mar 31, 2022 700,000.00
Dec 31, 2021 2.40 Mn
Sep 30, 2021 700.00
API Access

Kymera Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=KYMR&period=max&api_key=YOUR_API_KEY